ATE199717T1 - Benzothiophenverbindungen, ihre anwendungen und zusammensetzungen - Google Patents

Benzothiophenverbindungen, ihre anwendungen und zusammensetzungen

Info

Publication number
ATE199717T1
ATE199717T1 AT97305119T AT97305119T ATE199717T1 AT E199717 T1 ATE199717 T1 AT E199717T1 AT 97305119 T AT97305119 T AT 97305119T AT 97305119 T AT97305119 T AT 97305119T AT E199717 T1 ATE199717 T1 AT E199717T1
Authority
AT
Austria
Prior art keywords
compositions
phenyl
benzothiophene compounds
oco
alkyl
Prior art date
Application number
AT97305119T
Other languages
English (en)
Inventor
David Thompson Berg
George Joseph Cullinan
Brian William Grinnell
Mark Alan Richardson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE199717T1 publication Critical patent/ATE199717T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT97305119T 1996-07-15 1997-07-11 Benzothiophenverbindungen, ihre anwendungen und zusammensetzungen ATE199717T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2178896P 1996-07-15 1996-07-15

Publications (1)

Publication Number Publication Date
ATE199717T1 true ATE199717T1 (de) 2001-03-15

Family

ID=21806155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97305119T ATE199717T1 (de) 1996-07-15 1997-07-11 Benzothiophenverbindungen, ihre anwendungen und zusammensetzungen

Country Status (10)

Country Link
US (2) US5948795A (de)
EP (1) EP0819687B1 (de)
JP (1) JPH1067774A (de)
AT (1) ATE199717T1 (de)
CA (1) CA2207141A1 (de)
DE (1) DE69704235T2 (de)
DK (1) DK0819687T3 (de)
ES (1) ES2155655T3 (de)
GR (1) GR3035981T3 (de)
PT (1) PT819687E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2259376T3 (es) * 2001-05-22 2006-10-01 Eli Lilly And Company 1,2,3,4-tetrahidroquinolinas 2-sustituidas y sus derivados, composiciones y procedimientos.
ES2236536T3 (es) * 2001-05-22 2005-07-16 Eli Lilly And Company Derivados tetrahidroquinolino para la inhibicion de enfermedades asociadas con la privacion de estrogenos o con una respuesta fisiologica aberrante a estrogenos endogenos.
TWI224101B (en) * 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
TWI240723B (en) 2001-06-20 2005-10-01 Wyeth Corp Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
US7446201B2 (en) * 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7163954B2 (en) * 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
EP1687292B1 (de) * 2003-11-20 2007-08-22 Eli Lilly And Company Modulatoren des vitamin-d-rezeptors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE339235B (de) * 1965-06-01 1971-10-04 Haessle Ab
US3598839A (en) * 1969-06-30 1971-08-10 Parke Davis & Co Phenylbenzothiophene compounds
US3935231A (en) * 1972-10-17 1976-01-27 Sandoz Ltd., (Sandoz Ag) Novel benzothiophene derivatives as stabilizers for organic compounds
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
IL65404A0 (en) * 1981-04-03 1982-07-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
US5175184A (en) * 1982-10-19 1992-12-29 Kotobuki Seiyaku Company Limited Benzothiophene derivatives and antihyperuricemia thereof
GB8417559D0 (en) * 1984-07-10 1984-08-15 Pfizer Ltd Anti-diarrhoeal agents
JPH04312526A (ja) * 1991-04-09 1992-11-04 Fujisawa Pharmaceut Co Ltd 骨疾患治療剤
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US5466810A (en) * 1994-06-10 1995-11-14 Eli Lilly And Company 2-amino-3-aroyl-benzo[β]thiophenes and methods for preparing and using same to produce 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-aminoethoxy)-benzoyl]benzo[β]thiophenes
US5532382A (en) * 1995-03-13 1996-07-02 Eli Lilly And Company Benzothiophenes substituted at the 3-carbonyl
US5731328A (en) * 1995-10-10 1998-03-24 Eli Lilly And Company Methods of inhibiting plasminogen activator inhibitor 1

Also Published As

Publication number Publication date
EP0819687B1 (de) 2001-03-14
EP0819687A1 (de) 1998-01-21
ES2155655T3 (es) 2001-05-16
US5948795A (en) 1999-09-07
DK0819687T3 (da) 2001-04-17
GR3035981T3 (en) 2001-08-31
US5962698A (en) 1999-10-05
CA2207141A1 (en) 1998-01-15
DE69704235T2 (de) 2001-09-06
DE69704235D1 (de) 2001-04-19
JPH1067774A (ja) 1998-03-10
PT819687E (pt) 2001-06-29

Similar Documents

Publication Publication Date Title
ATE251150T1 (de) Benzothiophenverbindungen, ihre anwendungen und zusammensetzungen
DK0792641T3 (da) Anvendelse af estrogenantagonister og estrogenagonister til hæmning af patologiske tilstande
BE2018C008I2 (de)
IL160304A (en) Compounds and composition for activating peroxisome proliferators-responsive receptor ??
DE60006216D1 (de) Chinolinderivate und chinazolinderivate
FI943561A0 (fi) Uudet ainekoostumukset
ATE277011T1 (de) Flouride von 4-substituierten piperidin-derivaten
AU755654C (en) Novel amide compounds and drugs containing the same
YU83993A (sh) Novi derivati piridon organske kiseline
ATE232528T1 (de) Pyrimidinylpyrazolderivate
DE69704235D1 (de) Benzothiophenverbindungen, ihre Anwendungen und Zusammensetzungen
DE60223904D1 (de) Benzylaminanalogen
DK0404359T3 (da) Dibenzothiazepin-derivater, der er nyttige som antispasmodiske midler
EP1209151A4 (de) In 4-stellung substituierte piperidinderivate
DK1559714T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivater og 3-aminothiophenderivater
ATE201402T1 (de) Optisch aktive thiazolidinonderivate
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
ATE284379T1 (de) Aminderivate
FI944207A0 (fi) Cyclohexane derivatives
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee